Effect of Natural Compounds on P-glycoprotein Activity in Human Uterine Sarcoma Cells
![]() |
Chung, Soo-Yeon
(College of Pharmacy, Ewha Womans University)
Go, Eun-Jung (College of Pharmacy, Ewha Womans University) Kim, Na-Hyung (College of Pharmacy, Ewha Womans University) Sung, Min-Kyung (College of Pharmacy, Ewha Womans University) Jang, Jung-Ok (College of Pharmacy, Ewha Womans University) Lee, Hwa-Jeong (College of Pharmacy, Ewha Womans University) |
1 | B.L. Lum and M.P. Gosland, MDR expression in normal tissues. Pharmacologic implications for the clinical use of P-glycoprotein inhibitors. Hematol. Oncol. Clin. North Am., 9, 319-336 (1995) |
2 | M.F. Fromm, P-glycoprotein: A defense mechanism limiting oral bioavailability and CNS accumulation of drug, Int. J. Clin. Pharmacol. Ther., 38, 69-74 (2000) DOI |
3 | R.W. Stenkampf and W.D. Klohs, Possible link between the intrinsic drug resistance of colon tumor and a detoxification mechanism of intestinal cell, Cancer Res., 48, 3025-3030 (1988) |
4 |
J.M. Phang, C.M. Poore, J. Lopaczynska and G.C. Yeh, Flavol-stimulated efflux of 7,12-dimethylbenz( |
5 | T. Ikegawa, H. Ohtani, N. Koyabu, M. Juichi, Y Iwase, C. Ito, H. Furukawa, M. Naito, T. Tsuruo and Y. Sawada, Inhibition of P-glycoprotein by flavonoid derivatives in adriamycin-resistant human myelogenous leukemia (K562/ADM) cell, Cancer lett., 177, 89-93 (2002) DOI ScienceOn |
6 | N.P. Singh and H. Lai, Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells, Life Sei., 70,49-56 (2001) DOI ScienceOn |
7 | T. Efferth, H. Dunstan, A. Sauerbrey, H. Miyachi and C.R. Chitambar, The anti-malarial artesunate is also active against cancer, Int. J. Oncol., 18, 767-773 (2001) |
8 | A.H. Amin, T.V. Subbaiah and K.M. Abbasi, Berberine sulfate: antimicrobial activity, bioassay, and mode of action, Can. J. Microbiol., 15, 1067-76 (1969) DOI ScienceOn |
9 | W.G. Harker, E.R. Mackintosh and B.I. Sikic, Development and characterization of a human sarcoma cell line, MES-SA, sensitive to multiple drug, Cancer Res., 43, 4943-4950 (1983) |
10 | J.W. Critchfield, C.J. Welsh, J.M. Phang and G.C. Yeh, Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells: activation of P-glycoprotein as a putative mechanisms, Biochem. Pharmacol., 48, 1437-1445 (1994) DOI ScienceOn |
11 | V. Elangovan, N. Sekar and S. Govindasamy, Chemopreventive potential of dietary bioflavonoids against 20-methylcholanthrene-induced tumorigenesis, Cancer Lett., 87, 107-13 (1994) DOI ScienceOn |
12 | I.M. Liu and S.J. Sheu, Analysis and processing of Chinese herbal drugs. VIII: The study of sophorae floe. Am. J. Chin. Med, 17, 179-87 (1989) DOI ScienceOn |
13 | T. Tanaka, K. Kawabata, S. Honjo, Tanaka T., H. Kohno, M. Murakami, R Shimada, K. Matsunaga, Y. Yamada and M. Shimizu, Inhibition of azoxymethane-induced aberrant crypt foci in rats by natural compounqs, caffeine, quercetin and morin, Oncol. Rep., 6, 1335-40 (1999) |
14 | H. Saloniemi, K. Wahala, P. Nykanen-kurki, K. Kallela and I. Saastamoinen, Phytoestrogen content and estrogenic effect of legume fodder, Pros. Soc. Exp. Biol, Med., 208, 13-17 (1995) DOI |
15 |
Y.S. Lee, T.H. Kim, K.J. Cho and J.J. Jang, Inhibitory effects of biochanin A on benzo[ |
16 | T. Gotoh, K. Yamada, H. Yin, A. Ito, T. Kataoka and K. Dohi, Chemoprevention of N-nitroso-N-methylurea-induced rat manunary carcinogenesis by soy foods or biochanin A. Jpn. J. Cancer Res., 89, 137-142 (1998) DOI |
17 | W.M. Keung, O. Lazo, L. Kunze and B.L. Vallee, Potentiation of the bioavailability of daidzein by an extract of Radix puerariae, Proc. Natl. Acad Sci. USA, 93, 4284-4288 (1996) |
18 | W.M. Keung, O. Lazo, L. Kunze and B.L. Vallee, Daidzein suppresses ethanol consumption by Syrian golden hamsters without blocking acetaldehyde metabolism, Proc. Natl. Acad Sci. USA, 92, 8990-8993 (1995) |
19 | P.F. Juranka, R.I. Zastawny and V. Ling, P-glycoprotein multidrug resistance and a superfamily of membraneassociated transport proteins, FASEB J., 3, 2583-2592 (1989) DOI |
20 | S.A.W. Fuqua, I.M. Moretti-Rojas, S.L. Schneider and W.L. McGuire, P-glycoprotein expression in human breast cancer cells, Cancer Res., 47, 2103-2106 (1987) |
21 | T. Efferth, A Sauerbrey, M.E. Halatsch, D.D. Ross and E. Gebhart, Molecular modes of action of cephalotaxine and homoharringtorrine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines, Naunyn Schmiedebergs Arch. Pharmacol., 367, 56-67 (2002) |
22 | R.P. Singh and R. Agarwal, Prostate cancer prevention by silibirin, Curr. Cancer Drug Targets, 4, 1-11 (2004) DOI ScienceOn |
23 | K. Kropachova and E. Mishurova, Flavobion and thioctacid lessen irradiation-induced latent injury of the liver, Biull. Eksp. Bioi. Med, 113, 547-549 (1992) |
24 | M. Velussi, A.M. Cemigoi, A De Monte, F. Dapas, C. Caffau and M. Zilli, Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients, J. Hepatol., 26, 4871-4879 (1997) |
25 | P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenny and M.R. Boyd, New colorimetric cytotoxicity assay for anticancerdrug screening, J. Natl. Cancer. Inst., 82, 1107-1112 (1990) DOI |
26 | G. Harker and B.I. Sikic, Multidrug (pleiotropic) resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA, Cancer Res., 45, 4091-4096 (1985) |
27 | J.A. Endicott and V. Ling, The biochemistry of Pglycoprotein-mediated multidrug resistance, Ann. Rev. Biochem., 58, 137-171 (1989) DOI ScienceOn |
28 | M.M. Gottesman and I. Pasran, Biochemistry of multi drug resistance mediated by the multidrug transporter, Ann. Rev. Biochem., 62, 385-427 (1993) DOI ScienceOn |
29 | F. Theibaut, T. Tsuruo, H. Hamada, M.M. Gottesman, I. Pastan and M.C. Willingham, Localization of the multidrug resistance gene product P-glycoprotein in normal human tissues, Proc. Natl. Acad. Sci., 84,7735-7738 (1987) |
30 | E.J. Go, S.Y. Chung, N.H. Kim and H.J. Lee, Modulation of P-glycoprotein activity by flavonoids in human uterine sarcoma cells, J. Kor. Pharm. Sci., 33, 305-310 (2003) |
31 | S.Y. Chung, E.J. Go, N.H. Kim and H.J. Lee, Effect of flavonoids on efflux and cytotoxicity of daunomycin, J. Kor. Pharm. Sci., 34, 95-99 (2004) |
32 | G. Scambia, F.O. Ranelleti, P.B. Panici, R. DiVincenzo, G. Bonanno, G. Ferrandina, M. Piantelli, S. Bussa, C. Rumi, M. Cianfriglia and S. Mancuso, Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast cancer cell line: P-glycoprotein as a possible target, Cancer Chemother. Pharmacol., 34, 459-464 (1994) DOI ScienceOn |
33 |
G.C. Yeh, J. Lopaczynska, C.M. Poore and J.M. Phang, A new functional role for P-glycoprotein: Efflux pump for benzo[ |
34 | T. Efferth, M. Davey, A. Olbrich, G. Rucker, E. Gebhart and R. Davey, Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells, Blood Cells Mol. Dis., 28, 160-168 (2002) DOI ScienceOn |
35 | E. Chieli, N. Romiti, F. Cervelli and R. Tongiani, Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes, Life Sci., 57, 1741-1751 (1995) DOI ScienceOn |
36 | S. Zhang and M.E. Morris, Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport, J. Pharmacol. Exp. Ther., 304, 1258-1267 (2003) DOI ScienceOn |
37 | L. Movileanu, I. Neagoe and M.L. Flonta, Interation of the antioxidant flavonoid quercetin with planar lipid bilayers, Int. J. Pharm., 205, 135-146 (2000) DOI ScienceOn |
38 | V.J. Wacher, L. Salphati and L.Z. Benet, Active secretion and enterocyte drug metabolism barriers to drug absorption. Adv. Drug Del. Rev., 20, 99-112 (1996) DOI ScienceOn |
![]() |